Literature DB >> 26779893

Systematic Review and Meta-analysis of Atrial Fibrillation Prophylaxis After Lung Surgery.

Liangze Zhang1, Shugeng Gao.   

Abstract

Atrial fibrillation (AF), which increases morbidity and mortality, is a common occurrence after thoracic surgery and pulmonary resection. Despite several investigations on various prophylactic measures for AF prevention, the studies were not uniform and do not use similar controls making it difficult to arrive at a meaningful conclusion. In the present systematic analysis review, we evaluated the efficacy of different prophylactic approaches to prevent AF after lung surgery in randomized trials reported during 1991-2014. A total of 12 trials were identified that met the criteria set for this meta-analysis. Among different trials, amiodarone was found to be most effective in preventing postoperative AF (risk ratio, 0.22; P < 0.0001; 95% confidence interval: 0.09-0.54). There were no significant prophylactic effects by MgSO4 (risk ratio, 1.24; P < 0.007; 95% confidence interval, 0.27-5.68), digoxin, or Ca blockers. Single use of amiodarone was able to lower the incidence of AF from 39.2% to 8.3% and seemed to be safe with no major complications. Although several prophylactic measures have been tried to curtail the incidence of AF in patients after lung surgery, prophylaxis with amiodarone seems to be most effective of treatments studied.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26779893     DOI: 10.1097/FJC.0000000000000351

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

Review 1.  A review and analysis of strategies for prediction, prevention and management of post-operative atrial fibrillation after non-cardiac thoracic surgery.

Authors:  Heather Smith; Ching Yeung; Stephen Gowing; Mouhannad Sadek; Donna Maziak; Sebastien Gilbert; Farid Shamji; Patrick Villeneuve; Sudhir Sundaresan; Andrew Seely
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

2.  Analysis of the risk factors of postoperative cardiopulmonary complications and ability to predicate the risk in patients after lung cancer surgery.

Authors:  Yue Li; Yin-Lu Ma; Yong-Yin Gao; Dan-Dan Wang; Qing Chen
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

Review 3.  Pharmacological interventions for preventing atrial fibrillation after lung surgery: systematic review and meta-analysis.

Authors:  Xiaomei Wang; Demei Zhang; Yanxia Ren; Jingjing Han; Guangling Li; Xueya Guo
Journal:  Eur J Clin Pharmacol       Date:  2022-09-22       Impact factor: 3.064

4.  Risk Factors and In-Hospital Outcomes of Perioperative Atrial Fibrillation for Patients with Cancer: A Meta-Analysis.

Authors:  Keiko Inoue; Kazuko Tajiri; DongZhu Xu; Nobuyuki Murakoshi; Masaki Ieda
Journal:  Ann Surg Oncol       Date:  2022-10-22       Impact factor: 4.339

Review 5.  Incidence, Management, Prevention and Outcome of Post-Operative Atrial Fibrillation in Thoracic Surgical Oncology.

Authors:  Iacopo Fabiani; Alessandro Colombo; Giulia Bacchiani; Carlo Maria Cipolla; Daniela Maria Cardinale
Journal:  J Clin Med       Date:  2019-12-23       Impact factor: 4.241

6.  Higher Mortality Associated With New-Onset Atrial Fibrillation in Cancer Patients: A Systematic Review and Meta-Analysis.

Authors:  Minha Murtaza; Mirza Mehmood Ali Baig; Jawad Ahmed; Liviu Ionut Serbanoiu; Stefan Sebastian Busnatu
Journal:  Front Cardiovasc Med       Date:  2022-04-14

7.  Efficacy of thoracoscopic surgery in the treatment of lung cancer in the perioperative period and its effects on serum D-dimer.

Authors:  Yuanshan Yao; Haibo Shen; Yinjie Zhou; Zhenhua Yang; Hongbo Huang
Journal:  Oncol Lett       Date:  2018-01-22       Impact factor: 2.967

8.  Prophylaxis for patients at Risk to Eliminate Post-operative Atrial Fibrillation (PREP-AF trial): a protocol for a feasibility randomized controlled study.

Authors:  Heather A Smith; Salmaan Kanji; Andrew J E Seely; Diem T T Tran; Calum Redpath; Dean Ferguson; Tori Lenet; Greg Sigler; Sebastien Gilbert; Donna Maziak; Patrick Villeneuve; Sudhir Sundaresan
Journal:  Trials       Date:  2021-06-07       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.